What happened
S Biomedics disclosed convertible bonds to raise US$12.1M, about 6.3% of its market value.
For context, this raise equals about 6.3% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$12.1M |
| vs. market value | 6.3% |
| Filed | 2026-04-14, Material event report (rights offering) |
| Source | DART rcept 20260414002160 → open original filing |
Source: DART. Information only, not investment advice.